As Kellogg Co Com (K) Valuation Declined, Cornercap Investment Counsel Has Increased Its Stake; Abbott Labs (ABT) Stock Rose While Portland Global Advisors Trimmed Its Holding

May 18, 2018 - By olga

Abbott Laboratories (NYSE:ABT) Logo

Cornercap Investment Counsel Inc increased its stake in Kellogg Co Com (K) by 43.01% based on its latest 2017Q4 regulatory filing with the SEC. Cornercap Investment Counsel Inc bought 22,845 shares as the company’s stock declined 5.46% with the market. The institutional investor held 75,955 shares of the packaged foods company at the end of 2017Q4, valued at $5.16 million, up from 53,110 at the end of the previous reported quarter. Cornercap Investment Counsel Inc who had been investing in Kellogg Co Com for a number of months, seems to be bullish on the $21.22 billion market cap company. The stock decreased 0.50% or $0.31 during the last trading session, reaching $61.18. About 1.79 million shares traded. Kellogg Company (NYSE:K) has declined 11.27% since May 18, 2017 and is downtrending. It has underperformed by 22.82% the S&P500.

Portland Global Advisors Llc decreased its stake in Abbott Labs (ABT) by 85.37% based on its latest 2017Q4 regulatory filing with the SEC. Portland Global Advisors Llc sold 22,956 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 3,934 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $225,000, down from 26,890 at the end of the previous reported quarter. Portland Global Advisors Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $107.05 billion market cap company. The stock increased 0.48% or $0.29 during the last trading session, reaching $61.06. About 4.16 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 18, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Cornercap Investment Counsel Inc, which manages about $912.27M and $729.53 million US Long portfolio, decreased its stake in Regions Finl Corp New Com (NYSE:RF) by 180,753 shares to 14,602 shares, valued at $252,000 in 2017Q4, according to the filing. It also reduced its holding in Universal Hlth Svcs Inc Cl B (NYSE:UHS) by 46,868 shares in the quarter, leaving it with 3,662 shares, and cut its stake in D R Horton Inc Com (NYSE:DHI).

More notable recent Kellogg Company (NYSE:K) news were published by: Prnewswire.com which released: “Prescience Point Capital Management Issues Negative Report on Kellogg Company (NYSE: K), Argues Shares Could …” on April 26, 2018, also Seekingalpha.com with their article: “Kellogg: An Unlikely Growth Company?” published on May 09, 2018, 247Wallst.com published: “6 Most Important Things in Business Today” on May 16, 2018. More interesting news about Kellogg Company (NYSE:K) were released by: Seekingalpha.com and their article: “Kellogg: Better Options For Dividend Growth” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “An Investment Overview On Alliance Data Systems” with publication date: May 17, 2018.

Since December 13, 2017, it had 0 insider buys, and 8 insider sales for $165.23 billion activity.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.05, from 0.86 in 2017Q3. It improved, as 60 investors sold K shares while 212 reduced holdings. 82 funds opened positions while 166 raised stakes. 309.07 million shares or 0.67% more from 307.00 million shares in 2017Q3 were reported. Ashfield Ptnrs Ltd Llc holds 0.03% or 3,408 shares in its portfolio. Spinnaker holds 3,612 shares. 3,232 are held by Ingalls & Snyder Llc. Ftb Advisors has 0.02% invested in Kellogg Company (NYSE:K) for 3,690 shares. Barclays Public Ltd holds 0.05% or 855,009 shares in its portfolio. Commerce Bank & Trust invested in 0.04% or 40,738 shares. Voya Mngmt Limited Liability Company owns 173,268 shares. Brown Brothers Harriman & invested 0.01% in Kellogg Company (NYSE:K). Cibc holds 0% or 14,666 shares. Nikko Asset Americas Incorporated holds 0% or 1,800 shares. Brown Advisory Limited Liability Corporation has 6,395 shares. Inv House Limited Liability Co holds 5,275 shares or 0.04% of its portfolio. Smith Chas P And Pa Cpas has 0.03% invested in Kellogg Company (NYSE:K) for 3,720 shares. Janney Montgomery Scott Lc reported 0.02% stake. Everence Mgmt Incorporated invested in 10,489 shares or 0.16% of the stock.

Among 27 analysts covering Kellogg Company (NYSE:K), 10 have Buy rating, 3 Sell and 14 Hold. Therefore 37% are positive. Kellogg Company had 79 analyst reports since August 5, 2015 according to SRatingsIntel. Credit Suisse maintained it with “Neutral” rating and $70 target in Tuesday, February 6 report. The firm has “Sector Perform” rating given on Friday, August 5 by RBC Capital Markets. As per Tuesday, December 8, the company rating was upgraded by Morgan Stanley. RBC Capital Markets maintained it with “Sector Perform” rating and $81 target in Friday, May 5 report. On Thursday, April 14 the stock rating was maintained by Citigroup with “Buy”. The rating was maintained by JP Morgan with “Overweight” on Tuesday, May 1. The stock of Kellogg Company (NYSE:K) has “Sector Perform” rating given on Friday, February 12 by RBC Capital Markets. The company was maintained on Friday, February 9 by Morgan Stanley. The firm earned “Hold” rating on Monday, April 16 by Credit Suisse. On Wednesday, November 1 the stock rating was maintained by UBS with “Neutral”.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Jefferies on Wednesday, April 18. Jefferies maintained the stock with “Buy” rating in Thursday, July 14 report. RBC Capital Markets maintained it with “Outperform” rating and $50 target in Wednesday, March 1 report. The stock has “Buy” rating by Jefferies on Wednesday, January 24. The firm earned “Buy” rating on Tuesday, September 13 by Jefferies. The firm has “Neutral” rating by Goldman Sachs given on Friday, November 13. Jefferies maintained the stock with “Buy” rating in Friday, June 16 report. The stock of Abbott Laboratories (NYSE:ABT) has “Neutral” rating given on Tuesday, September 22 by UBS. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) rating on Monday, June 26. RBC Capital Markets has “Buy” rating and $5400 target. Citigroup maintained Abbott Laboratories (NYSE:ABT) on Tuesday, April 24 with “Neutral” rating.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24B for 21.50 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Portland Global Advisors Llc, which manages about $321.25M and $269.69M US Long portfolio, upped its stake in Ishares Msci Eafe Index (EFA) by 5,028 shares to 276,066 shares, valued at $19.41M in 2017Q4, according to the filing.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Mycio Wealth owns 9,042 shares for 0.06% of their portfolio. Davidson has invested 0.06% in Abbott Laboratories (NYSE:ABT). Sfe Counsel reported 2.87% of its portfolio in Abbott Laboratories (NYSE:ABT). Town And Country National Bank & Trust And Tru Dba First Bankers Tru accumulated 1.44% or 51,189 shares. Garde Capital stated it has 0.1% of its portfolio in Abbott Laboratories (NYSE:ABT). Crestpoint Mgmt Lc stated it has 2.1% of its portfolio in Abbott Laboratories (NYSE:ABT). Alphamark Advisors Ltd Liability Company has 0% invested in Abbott Laboratories (NYSE:ABT). 267,992 are held by John G Ullman Associates Inc. Moreover, Gabelli Com Inv Advisers has 0.03% invested in Abbott Laboratories (NYSE:ABT) for 4,500 shares. Moreover, Boltwood Mgmt has 0.92% invested in Abbott Laboratories (NYSE:ABT) for 26,350 shares. Iguana Healthcare Management Ltd owns 75,000 shares. Acg Wealth reported 8,023 shares. Grimes holds 0.19% or 34,198 shares. Keybank Association Oh, a Ohio-based fund reported 1.27M shares. Us Commercial Bank De has invested 0.55% in Abbott Laboratories (NYSE:ABT).

Kellogg Company (NYSE:K) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>